logo
Plus   Neg
Share
Email

Illumina To Acquire Pacific Biosciences At $8.00/shr - Quick Facts

Illumina, Inc. (ILMN) and Pacific Biosciences (PACB) announced an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction. This price represents a total enterprise value of approximately $1.2 billion on a fully diluted basis. Illumina expects to close the transaction in mid-2019.

Pacific Biosciences of California, Inc. offers sequencing systems to help scientists resolve genetically complex problems. PacBio sequencing systems, including consumables and software, provide a simple, fast, end-to-end workflow for Single Molecule, Real-Time Sequencing.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Procter & Gamble Company (PG) reported that its second-quarter core earnings per share rose 14 percent year-on-year, due to lower non-core restructuring charges versus the prior year. Currency-neutral core earnings per share increased 15 percent. Organic sales were up five percent, for the quarter.... While reporting financial results for the fourth quarter on Thursday, JetBlue Airways Corp. (JBLU) provided its financial outlook for the first quarter and the full-year 2020. For the first quarter, the company expects earnings in a range of $0.10 to $0.20 per share. Capacity is expected to increase... Five Star Food Inc. is recalling certain Sham Gardens Excellent tahina containers for potential contamination with Salmonella, the US Food and Drug Administration said in a statement. The recall involves 100 cases of Excellent tahina 800 g and 100 cases of Excellent tahina 400 g containers. The Garden City, Michigan-based company, however, has not received any reports of illness.
RELATED NEWS
Follow RTT
>